Scotiabank Initiates Coverage On Ocular Therapeutix with Sector Outperform Rating, Announces Price Target of $22
Portfolio Pulse from Benzinga Newsdesk
Scotiabank has initiated coverage on Ocular Therapeutix with a Sector Outperform rating and set a price target of $22.
October 16, 2024 | 2:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Scotiabank has initiated coverage on Ocular Therapeutix with a Sector Outperform rating and a price target of $22, indicating a positive outlook.
The initiation of coverage with a Sector Outperform rating and a price target of $22 by Scotiabank suggests a positive outlook for Ocular Therapeutix. This could lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100